This document is an excerpt from the EUR-Lex website
Document C:2015:397:TOC
Official Journal of the European Union, C 397, 28 November 2015
Official Journal of the European Union, C 397, 28 November 2015
Official Journal of the European Union, C 397, 28 November 2015
ISSN 1977-091X |
||
Official Journal of the European Union |
C 397 |
|
![]() |
||
English edition |
Information and Notices |
Volume 58 |
Notice No |
Contents |
page |
|
II Information |
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2015/C 397/1 |
Non-opposition to a notified concentration (Case M.7821 — Ardian France/Solina) ( 1 ) |
1 |
2015/C 397/2 |
Non-opposition to a notified concentration (Case M.7790 — Carrefour Group/Rue du Commerce) ( 1 ) |
1 |
|
IV Notices |
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Parliament |
|
2015/C 397/3 |
2 |
|
|
European Commission |
|
2015/C 397/4 |
9 |
|
V Announcements |
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMMON COMMERCIAL POLICY |
|
|
European Commission |
|
2015/C 397/5 |
10 |
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
|
|
European Commission |
|
2015/C 397/6 |
Prior notification of a concentration (Case M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications)) ( 1 ) |
20 |
|
|
|
(1) Text with EEA relevance |
EN |
|